Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Supporting the Clean Energy Industry Through the COVID-19 Response

A Letter to the Clean Energy Industry Businesses and Employees Without doubt, Zinc8 Energy Solutions Inc. has the best possible partners to continue its path to full commercialization of its unique, patented, low-cost, long-duration energy storage system. On Apr...
Stephan Bogner | April 2, 2020 |

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...
Featured Submission | August 13, 2021 |

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson | October 8, 2020 |

This Cannabis Co. is Mounting its COVID-Comeback

The COVID-19 coronavirus pandemic has forced a massive shift in businesses across the board and this is especially true for 1933 Industries (TGIF) ( CSE:TGIF , OTCQX: TGIFF , Forum ), who reported that during its Q3 2020 , its revenues were adversely impacted by closures...
Dave Jackson | July 24, 2020 |

As Said, the S&P 500 Grind Higher Goes On

Yesterday’s sizable bullish gap immediately came under attack by the sellers – no panicking though as I kept riding the bull to the glorious close and beyond. In such moments, it’s key to focus on what has changed, and what has not. The obvious ...
Monica Kingsley | May 28, 2020 |

Wild Volatility Continues As US Markets Attempt To Establish New Trend

We’ve continued to attempt to warn investors of the risks ahead for the US and global markets by generating these research posts and by providing very clear data supporting our conclusions. Throughout the entire months of May and June, we’ve s...
Chris Vermeulen | July 2, 2020 |

How to Invest in Metals & Mining Stocks

As most investors to Stockhouse know, the global mining industry is massive. And growth in certain critical sectors (i.e. Platinum Metals Groups) is expected continue at a rate that sometimes exceeds supply. The S&P TSX Gold Index consists of 70 precious metal mining compa...
Stockhouse Editorial | January 17, 2020 |

This Is What First Lagarde’s Speech Means for Gold

In November, Lagarde delivered her first speech as the ECB President. Will she follow in Draghi’s footsteps? But what should gold investors expect from her? Key Takeaways from Lagarde’s Speech Recently, we have focused on the U.S. econo...
Arkadiusz Sieron | December 6, 2019 |

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia ...

Syndax Pharma Shares Rise on $35M Capital Raise, Credit Line and Positive Phase 1/2 Leukemia Trial Results Syndax Pharmaceuticals' shares traded 30% higher after the company reported it expects to raise $35 million from a common stock offering from five instituti...
Streetwise Reports | February 3, 2020 |

Fed Cut Equities Stimulus 86% This Week and Stocks Are Falling

What happens to the global markets when the US Fed begins to weaken stimulus activity and when the global markets must begin to function on their own? Are the global markets capable of sustaining current price levels without the Fed supporting them? A recent news article s...
Chris Vermeulen | May 1, 2020 |
1 2 3 4 5 6 7 8 9 10 ...